Validations: Hold-Time Studies (Bulk, Intermediate & Cleaning)

Template Pack: Protocol, Report, and Log Sheets

Template Pack: Protocol, Report, and Log Sheets Template Pack: Protocol, Report, and Log Sheets In the pharmaceutical industry, maintaining compliance with regulatory expectations surrounding hold time studies is essential for ensuring product quality and patient safety. This guide outlines a systematic approach to developing documentation for hold-time studies pertaining to bulk materials, intermediate products, and cleaning processes. Following these protocols…

Continue Reading Template Pack: Protocol, Report, and Log Sheets

When to Retire Hold Claims: Trending Evidence

When to Retire Hold Claims: Trending Evidence When to Retire Hold Claims: Trending Evidence Introduction to Hold Claims in Pharmaceutical Manufacturing In pharmaceutical manufacturing, the understanding and management of hold times for different processes, namely bulk hold time and intermediate hold time, represent crucial steps in ensuring product quality and compliance with regulatory guidelines such as FDA and EMA. Hold…

Continue Reading When to Retire Hold Claims: Trending Evidence

Storyboarding Hold-Time for Inspections

Storyboarding Hold-Time for Inspections Storyboarding Hold-Time for Inspections Hold-time studies are a critical aspect of pharmaceutical validation processes, especially when it pertains to the retention of bulk intermediates and cleaning processes. Regulatory bodies such as the US FDA, EMA, and MHRA scrutinize these studies to ensure compliance with established guidelines. This article will guide pharmaceutical professionals through the steps involved…

Continue Reading Storyboarding Hold-Time for Inspections

SOP Architecture for Hold-Time: Roles and Interlocks

SOP Architecture for Hold-Time: Roles and Interlocks In the pharmaceutical industry, hold-time studies are a crucial component of cGMP (current Good Manufacturing Practices) compliance. Understanding the roles and interlocks in the Standard Operating Procedures (SOPs) related to hold-times for bulk and intermediate products is vital for regulatory adherence. This article serves as a comprehensive guide to the SOP architecture surrounding…

Continue Reading SOP Architecture for Hold-Time: Roles and Interlocks

Bridging Hold-Time to Validation Master Plan

Bridging Hold-Time to Validation Master Plan Bridging Hold-Time to Validation Master Plan In the pharmaceutical manufacturing landscape, compliance with Good Manufacturing Practices (cGMP) is critical. One crucial aspect that aligns with these regulations is the effective management of hold-time studies related to bulk and intermediate products, cleaning holds, and equipment utilization. Understanding the interrelation of hold-time studies with the Validation…

Continue Reading Bridging Hold-Time to Validation Master Plan

KPIs for Hold-Time: On-Time, Right-First-Time, and Repeat Findings

KPIs for Hold-Time: On-Time, Right-First-Time, and Repeat Findings KPIs for Hold-Time: On-Time, Right-First-Time, and Repeat Findings In the pharmaceutical industry, maintaining the integrity and quality of products during hold times is critical for compliance with FDA, EMA, and MHRA regulations. This article aims to provide a comprehensive guide on the key performance indicators (KPIs) related to hold time studies, focusing…

Continue Reading KPIs for Hold-Time: On-Time, Right-First-Time, and Repeat Findings

Data Historians for Hold Attributes: Storage and Access

Data Historians for Hold Attributes: Storage and Access The integrity of pharmaceutical operations hinges on stringent validation protocols, particularly relating to hold times for bulk and intermediate products, and cleaning processes. Hold-time studies are essential for understanding the microbial limits, bioburden trending, and acceptance criteria necessary for regulatory compliance. This article provides a comprehensive step-by-step tutorial aimed at QA, QC,…

Continue Reading Data Historians for Hold Attributes: Storage and Access

Management Review Minutes: Evidence of Control

Management Review Minutes: Evidence of Control Management Review Minutes: Evidence of Control Pharmaceutical validation encompasses a multitude of processes ensuring compliance with Good Manufacturing Practices (cGMP) and regulatory standards established by agencies such as the US FDA, EMA, and MHRA. This article serves as a comprehensive step-by-step tutorial guide detailing the documentation required for management review minutes related to equipment…

Continue Reading Management Review Minutes: Evidence of Control

Linking Hold-Time to CPV: Integrated Signals

Linking Hold-Time to CPV: Integrated Signals In the pharmaceutical industry, ensuring product quality and compliance with regulatory requirements is paramount. A critical component of this process is the validation of hold-times for equipment and bulk materials, which directly influences product safety and efficacy. This tutorial serves as a step-by-step guide for professionals involved in validation, quality assurance, and regulatory affairs,…

Continue Reading Linking Hold-Time to CPV: Integrated Signals

Record Retention and Retrieval: Audit Expectations

Record Retention and Retrieval: Audit Expectations Record Retention and Retrieval: Audit Expectations The pharmaceutical industry is governed by stringent regulations regarding the documentation and retention of data for processes involving hold time studies. This tutorial provides an in-depth overview of the audit expectations related to record retention and retrieval, specifically focusing on bulk and intermediate hold times, sampling plans, acceptance…

Continue Reading Record Retention and Retrieval: Audit Expectations